Catalyst Wire Dossier Catalyst Wire Dossier

NerBloc

botulinum toxin type B · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NerBloc, covering 2018-07-11 to 2018-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

See pricing